Federal Circuit Reverses Construction, Remands Patent Dispute

Federal Circuit Reverses Construction, Remands Patent Dispute

WASHINGTON, D.C. - A New Jersey federal judge "misinterpreted" various claims of a patented drug used as an active ingredient in antihistamines, the Federal Circuit U.S. Court of Appeals ruled May 20 (Aventis Pharmaceuticals Inc., et al. v. Amino Chemicals Ltd., et al., No. 11-1335, Fed. Cir.).

Find full version on lexis Advance®
Access this news story on lexis.com®